AIFF vs EXAS · rev $999.0K vs rev $2.76B
Firefly Neuroscience, Inc. (AIFF) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Firefly Neuroscience, Inc. (AIFF) is a software - application company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported AIFF revenue for 2026-06-30 was $999.0K. Net income was -$4.0M. AIFF currently screens at market cap $38.8M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
AIFF currently screens at market cap $38.8M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the AIFF and EXAS stock pages for the full models.
Not investment advice.